Literature DB >> 12907104

Risk of mesh erosion with sacral colpopexy and concurrent hysterectomy.

Shawna Brizzolara1, Anita Pillai-Allen.   

Abstract

OBJECTIVE: To examine short- and long-term mesh-related complications in women undergoing abdominal sacral colpopexy with concurrent hysterectomy, compared with women with a prior hysterectomy undergoing sacral colpopexy alone.
METHODS: Patient characteristics, hospital complications, postoperative clinical course, and long-term graft-related complications were reviewed for all women with genital prolapse who underwent abdominal sacral colopexy between 1996 and 1998. Women with concurrent hysterectomy were compared with women with vaginal prolapse after a prior hysterectomy.
RESULTS: One hundred twenty-four patients, 60 with concurrent hysterectomy and 64 with prior hysterectomy, were observed postoperatively for a median of 35.5 (0-74) months. Demographics of the two groups were similar, with a mean age of 65.1 +/- 9.4 years and a mean body mass index of 25.8 +/- 4.2 kg/m(2). Eighty percent of colpopexies used prolene synthetic mesh and 20% allograft material. Initial operative and hospital complications were rare in both groups and included a blood transfusion of 2 U, a ureteral transection, a wound infection, heart block, and an arrhythmia. Delayed graft complications included one mesh erosion in a patient with a prior hysterectomy that was managed by office resection (0.8%).
CONCLUSION: Concurrent hysterectomy with abdominal sacral colopopexy has a low incidence of mesh complications and can be used as a first-line treatment for genital prolapse.

Entities:  

Mesh:

Year:  2003        PMID: 12907104      PMCID: PMC1364470          DOI: 10.1016/s0029-7844(03)00515-5

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  24 in total

1.  Surgical management and prevention of vaginal vault prolapse.

Authors:  E Imparato; G Aspesi; E Rovetta; M Presti
Journal:  Surg Gynecol Obstet       Date:  1992-09

2.  Anatomic aspects of vaginal eversion after hysterectomy.

Authors:  J O DeLancey
Journal:  Am J Obstet Gynecol       Date:  1992-06       Impact factor: 8.661

3.  Abdominal sacral colpopexy in 163 women with posthysterectomy vaginal vault prolapse and enterocele. Evolution of operative techniques.

Authors:  M C Timmons; W A Addison; S B Addison; M G Cavenar
Journal:  J Reprod Med       Date:  1992-04       Impact factor: 0.142

4.  The effect of vaginal dissection on the pudendal nerve.

Authors:  J T Benson; E McClellan
Journal:  Obstet Gynecol       Date:  1993-09       Impact factor: 7.661

5.  Retrospective analysis of 711 patients operated on for pelvic relaxation in 1983-1989.

Authors:  H S Virtanen; J I Mäkinen
Journal:  Int J Gynaecol Obstet       Date:  1993-08       Impact factor: 3.561

6.  Vaginal versus abdominal reconstructive surgery for the treatment of pelvic support defects: a prospective randomized study with long-term outcome evaluation.

Authors:  J T Benson; V Lucente; E McClellan
Journal:  Am J Obstet Gynecol       Date:  1996-12       Impact factor: 8.661

7.  True incidence of vaginal vault prolapse. Thirteen years of experience.

Authors:  M Marchionni; G L Bracco; V Checcucci; A Carabaneanu; E M Coccia; F Mecacci; G Scarselli
Journal:  J Reprod Med       Date:  1999-08       Impact factor: 0.142

8.  Recurrent pelvic support defects after sacrospinous ligament fixation for vaginal vault prolapse.

Authors:  R L Holley; R E Varner; B P Gleason; L A Apffel; S Scott
Journal:  J Am Coll Surg       Date:  1995-04       Impact factor: 6.113

9.  Sacrocolpopexy: a retrospective study of a clinician's experience.

Authors:  S R Valaitis; S L Stanton
Journal:  Br J Obstet Gynaecol       Date:  1994-06

10.  Total abdominal hysterectomy at abdominal sacrovaginopexy: a comparative study.

Authors:  D M Fedorkow; R E Kalbfleisch
Journal:  Am J Obstet Gynecol       Date:  1993-09       Impact factor: 8.661

View more
  23 in total

Review 1.  Systematic review of the efficacy and safety of using mesh in surgery for uterine or vaginal vault prolapse.

Authors:  Xueli Jia; Cathryn Glazener; Graham Mowatt; David Jenkinson; Cynthia Fraser; Christine Bain; Jennifer Burr
Journal:  Int Urogynecol J       Date:  2010-06-15       Impact factor: 2.894

2.  Vaginal mesh erosion after transvaginal repair of cystocele using Gynemesh or Gynemesh-Soft in 138 women: a comparative study.

Authors:  X Deffieux; R de Tayrac; C Huel; J Bottero; A Gervaise; K Bonnet; R Frydman; H Fernandez
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-01-04

3.  Will hysterectomy at the time of sacrocolpopexy increase the rate of polypropylene mesh erosion?

Authors:  Serge P Marinkovic
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-08-04

4.  [Prolapse surgery].

Authors:  K P Jünemann; M Hamann; C Seif
Journal:  Urologe A       Date:  2005-03       Impact factor: 0.639

5.  [Vaginal descensus and prolapse. Which operative technique?].

Authors:  M F Hamann; C Seif
Journal:  Urologe A       Date:  2009-05       Impact factor: 0.639

Review 6.  Uterine-preserving POP surgery.

Authors:  Robert Gutman; Christopher Maher
Journal:  Int Urogynecol J       Date:  2013-11       Impact factor: 2.894

Review 7.  Complications of pelvic organ prolapse surgery and methods of prevention.

Authors:  Renaud de Tayrac; Loic Sentilhes
Journal:  Int Urogynecol J       Date:  2013-11       Impact factor: 2.894

8.  Lumbosacral spondylodiscitis: an unusual complication of abdominal sacrocolpopexy.

Authors:  N Rajamaheswari; Sugandha Agarwal; Krishnan Seethalakshmi
Journal:  Int Urogynecol J       Date:  2011-09-02       Impact factor: 2.894

9.  Robotic-assisted laparoscopic mesh sacrocolpopexy.

Authors:  Jason P Gilleran; Matthew Johnson; Andrew Hundley
Journal:  Ther Adv Urol       Date:  2010-10

10.  Effect of mesh width on apical support after sacrocolpopexy.

Authors:  Sunil Balgobin; Joseph L Fitzwater; Donald D McIntire; Imelda J Delgado; Clifford Y Wai
Journal:  Int Urogynecol J       Date:  2016-12-29       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.